Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07053969 · ClinicalTrials.gov registry record · NA

The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness

A NA study of Missing Teeth and Mucositis, sponsored by The University of Texas Health Science Center at San Antonio.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT07053969: Recruiting NA study of Missing Teeth and Mucositis, sponsored by The University of Texas Health Science Center at San Antonio.

NCT07053969 is a NA study of Missing Teeth and Mucositis that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 32 participants, above the 27-participant average among 4 other Missing Teeth trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07053969, a NA study of Missing Teeth and Mucositis, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

Scientists do research to answer important questions which might help change or improve the way we do things in the future. The investigators know that using Enamel Matrix Derivatives results in thicker gum tissues around teeth. This study will test to see if using EMD around implants results in thicker gum tissues around implants.

Primary Outcome

Mucosal thickness at 1 and 5mm below the free gingival margin will be measured

Interventions

  • DEVICE Enamel Matrix Derivative

Study Locations (1)

Texas

  • University of Texas Health Science Center at San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2025-08-31
Est. Completion 2027-09
Phase NA

What NCT07053969 shows while recruiting

NCT07053969 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, above the 27-participant average among 4 other Missing Teeth trials with a reported enrollment target (19% higher).

The record links to 4 conditions, with Missing Teeth appearing as the primary indexed condition, and to 1 intervention - of which Enamel Matrix Derivative is the first listed.

NCT07053969 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT07053969 about?

NCT07053969 is a clinical study titled "The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness". Scientists do research to answer important questions which might help change or improve the way we do things in the future. The investigators know that using Enamel Matrix Derivatives results in thicker gum tissues around teeth. This study will test to see if using EMD around implants results in th...

What is the current status of trial NCT07053969?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-08-31. Estimated completion is 2027-09.

What conditions does trial NCT07053969 study?

This clinical trial studies the following conditions: Missing Teeth, Mucositis, Periodontitis, Adult, Dental Implantation.

What interventions are being tested in trial NCT07053969?

The interventions under investigation include: Enamel Matrix Derivative (DEVICE).

Who is sponsoring clinical trial NCT07053969?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07053969 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Missing Teeth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07053969, the US trial registry maintained by the National Library of Medicine. NCT07053969 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.